Population characteristics of intrauterine device users in real-world clinical practice across Europe – insights from the EURAS-LCS12 study
Lisa Eggebrecht, Bauerfeind Anja, Boehnke Tanja, Rizzo Manuel, Hagemann Christine, Jens A. Lange, Viet Mareike, Karl Pauls, von Stockum Sophia, Klinghardt Moritz, Klaas Heinemann
•2025 Contraception and Reproductive Medicine. 2025; 10.1186/s40834-025-00353-8. → DOI
Contraception
Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS12
Boehnke Tanja, Bauerfeind Anja, Lisa Eggebrecht, Cellier Camille, Jens A. Lange, Klaas Heinemann, Madden Tessa
•2024 Contraception. 2024; https://doi.org/10.1016/j.contraception.2024.110444. → DOI
Contraception
Pregnancy and pregnancy outcomes in a prospective cohort study: Final Results from the Nexplanon Observational Risk Assessment Study (NORA)
Reed Suzanne, Do Minh Thai, Jens A. Lange, Koro Carol, Klaas Heinemann
•2022 Contraception. 2022; 10.1016/j.contraception.2022.109920. → DOI
Contraception
Long-term treatment of endometriosis with dienogest: Real-world results from the VIPOS study
Moehner Sabine, Becker Kerstin, Jens A. Lange, von Stockum Sophia, Serrani Marco, Klaas Heinemann
•2021 Journal of Endometriosis and Pelvic Pain Disorders. 2021; 10.1177/2284026521993688. → DOI
Endometriosis
Risk of depression and anemia in users of hormonal endometriosis treatments: Results from the VIPOS study
Moehner Sabine, Becker Kerstin, Jens A. Lange, von Stockum Sophia, Klaas Heinemann
•2020 European Journal of Obstetrics &Gynecology and Reproductive Biology. 2020; 212 – 217. 10.1016/j.ejogrb.2020.05.049. → DOI
Endometriosis
Real world data on Nexplanon® procedure-related events: final results from the Nexplanon observational risk assessment study (NORA)
Reed Suzanne, Do Minh Thai, Jens A. Lange, Koro Carol, Fox Michelle, Klaas Heinemann
•2019 Contraception. 2019; pii: S0010-7824(19)30131-3. 10.1016/j.contraception.2019.03.052. → DOI
Contraception